Core Viewpoint - The company, Lianjian Technology, has extensive experience in the construction industry, focusing on building inspection, testing, and evaluation, and is well-equipped to provide integrated solutions for structural safety and quality enhancement [2]. Group 1: Company Expertise and Services - The company has qualifications for structural testing and can conduct various engineering quality inspections and structural evaluations, as well as real-time monitoring of building safety [2]. - It emphasizes the development of quality assurance and enhancement services for existing buildings and municipal infrastructure, particularly in urban renewal and renovation projects [2]. - The company has established research collaborations with institutions such as the Beijing Residential Building Design Institute and the Jiangsu Architectural Vocational and Technical College to study housing safety and insurance systems [2]. Group 2: Achievements and Recognition - The company has received several honors, including being recognized as an excellent unit in the Jiangsu construction engineering quality testing industry and a 3A-rated enterprise for evaluation and consulting [2]. - It has participated in numerous judicial evaluations and has provided professional testing and evaluation reports for various cases, gaining significant project experience across different building types [2]. - Since 2022, the company has been involved in safety inspections of self-built houses across multiple provinces, receiving consistent recognition from local governments for its contributions [2].

Group 1: Company Operations and Acquisitions - The company has officially entered the automotive testing field through the acquisition of Guanbiao Testing, which provides comprehensive testing services for automobiles and components, enhancing its capabilities in various areas such as material, environmental reliability, electrical performance, and electromagnetic compatibility (EMC) [2] - Guanbiao Testing has obtained third-party testing qualifications from major automotive manufacturers including Geely, Chery, and NIO, expanding its recognition in both traditional and new energy vehicle sectors [2] - The company employs a three-dimensional acquisition strategy focusing on "regional penetration + track expansion + qualification enhancement" to achieve precise mergers and acquisitions, aiming to quickly gain regional qualifications and customer resources [2] Group 2: International Expansion - The company is advancing its global layout in phases, initially focusing on countries along the "Belt and Road" by establishing localized teams to provide tailored testing and certification services [2] - In the mid-term, the company plans to build R&D centers in mature technical standard markets such as Europe and the U.S. to absorb advanced experiences and promote mutual recognition of qualifications [2] - As of now, the company has established regional offices in countries like Vietnam, Thailand, and Indonesia, creating a grid service system that covers "Belt and Road" countries [2] Group 3: Building Safety and Research Initiatives - The company has extensive experience in building safety inspections and has established research collaborations with various institutions to study housing safety management and insurance systems [3] - It has received multiple honors, including being recognized as an excellent unit in construction quality testing in Jiangsu Province and a 3A-rated consulting enterprise [3] - The company has participated in nationwide safety inspections for self-built houses since 2022, covering a wide range of provinces and receiving recognition from local governments [3]

Core Viewpoint - Investing in health through regular check-ups is essential for early detection of potential health risks, but it should be understood as a risk screening tool rather than an absolute guarantee against all health issues [1]. Group 1: Screening vs. Diagnosis - The distinction between "screening" and "clinical diagnosis" is clear; screening is a broad risk detection tool aimed at large, asymptomatic populations, while diagnosis involves detailed examination of identified risks [3]. - Screening serves to discover clues and issue warnings, guiding individuals towards further diagnostic processes when necessary [3]. Group 2: Medical Uncertainty - Medical science inherently involves uncertainty, with sensitivity (correctly identifying disease) and specificity (correctly ruling out disease) being critical metrics for evaluating screening technologies [5]. - High sensitivity may lead to false positives, while high specificity may result in false negatives, necessitating a balance between the two for effective public screening programs [5]. Group 3: Dynamic Health Management - Regular check-ups should be viewed as a series of "snapshots" that create a dynamic health monitoring system, rather than a single assessment of health status [8]. - Understanding the limitations of screening technologies allows individuals to better utilize warning signals and take responsibility for their health [9].

Group 1: Company Performance Overview - In the first half of 2025, the company achieved a total outpatient and emergency service volume of 1.3191 million, a year-on-year increase of 5.42% [4] - The company reported operating revenue of CNY 2,034.31 million, a decrease of 15.95% year-on-year, and a net profit attributable to shareholders of CNY -164.96 million, a year-on-year decrease in loss of 4.98% [4] - The operating cash flow net amount was CNY 592.54 million, an increase of 12.75% compared to the same period last year [4] Group 2: Service and Operational Improvements - The company established a senior care center with 100 beds to cater to the needs of elderly patients, including those with Alzheimer's and other disabilities [2] - The company’s hospitals completed 636 clinical application filings for restricted technologies and published 39 SCI papers, enhancing their academic influence [2] - The company improved patient service experience by optimizing the hospitalization settlement and medical insurance reimbursement processes [3] Group 3: Financial Metrics and Cost Management - In Q2 2025, the company achieved operating revenue of CNY 1.037 billion, a quarter-on-quarter increase of 4.02% [4] - The management expense ratio in Q2 was 13.12%, a decrease of 0.95 percentage points from the previous quarter [4] - The company implemented cost control measures, including optimizing personnel costs and enhancing procurement efficiency [6] Group 4: Patient Demographics and Market Reach - The proportion of out-of-town patients at Xi'an Gaoxin Hospital increased to 35%, while at Xi'an International Medical Center Hospital, it rose to 42% from less than 10% [7] - The company is adapting to DRG payment reform, stabilizing inpatient service volume while expanding outpatient services [6] Group 5: Future Outlook and Strategic Initiatives - The company plans to enhance medical quality and service experience while implementing differentiated strategies to build competitive advantages [9] - The proton therapy center, set to open in 2025, will be the first of its kind in Northwest China, significantly improving cancer treatment capabilities in the region [9]

此外，在这场说明会上，爱康集团创始人、董事长兼CEO张黎刚一番言论引爆国内舆论场："当你指望 说，一个几百块钱的体检能帮你什么病都查出来，而要查单一的病，多花几千几万块钱的时候，你认为 这样的情况存在吗？" 随后爱康国宾给出了声明称，张黎刚上述言论被部分媒体断章取义后，以"爱康CEO：别指望几百块体 检什么病都查出来"为大标题，在网络上进行散布。由于上述内容系被部分媒体恶意进行断章取义、歪 曲原意，已构成对爱康集团名誉权的严重侵害。 快科技7月31日消息，爱康国宾CEO近日公开发言引来热议，在他看来没法预测体检者在某年某月得癌 症。 昨天爱康国宾召开媒体说明会，爱康国宾创始人、CEO张黎刚表示，肾目前没有任何相关的肿瘤标志物 用于辅助诊断，体检是随机性、机会性的检查，碰到了就是碰到了。 这也引发了网友的吐槽，既然没办法预测，那还让人体检干什么？ 【本文结束】如需转载请务必注明出处：快科技 责任编辑：雪花 ...

Core Viewpoint - The expansion of the service industry is a crucial driver for high-quality economic development and the creation of a high-quality life in China, with pilot experiences transforming into national standards [1][3]. Group 1: Service Industry Expansion - The Hainan Boao Lecheng International Medical Tourism Pilot Zone has introduced a full range of international medical tourism services, attracting numerous visitors and establishing itself as a "super interface" for China's medical openness [1]. - Since 2015, the comprehensive pilot program for expanding service industry openness has been implemented in 11 provinces and cities, continuously relaxing market access thresholds [1][2]. - In 2024, the service industry in the 11 pilot areas is expected to attract foreign investment of 293.2 billion yuan, accounting for about half of the national service industry foreign investment [1]. Group 2: Institutional Innovation and Policy Measures - The State Council has approved a new plan to accelerate the expansion of service industry openness, adding nine pilot cities and proposing 155 pilot tasks [2]. - Measures include allowing foreign-invested enterprises to reinvest without foreign exchange registration and facilitating the entry of foreign professionals in specific sectors [2]. - The focus is on addressing practical needs in daily operations and cross-border investments, thereby enhancing the dynamism and vitality of the service industry [2]. Group 3: Regional Development and Comparative Advantages - Pilot programs should align with the development positioning and comparative advantages of the regions, encouraging localities to explore innovative paths [3]. - Chengdu has introduced incentives and measures to optimize the foreign investment environment, while Shanghai's free trade zone has implemented a negative list for cross-border service trade [3]. - The service industry expansion is seen as a key element in promoting high-quality development and modernizing China's economy [3].

Core Insights - The article highlights the development of Boao, Hainan, as a symbol of China's openness, particularly in the context of the upcoming Boao Forum for Asia annual conference in 2025 [2] - Boao Lecheng International Medical Tourism Pilot Zone is emphasized as a new high ground for China's medical openness and cooperation, showcasing significant achievements in the introduction of innovative drugs and medical devices [2][3] Medical Industry - Over 460 types of first-use licensed drugs and medical devices have benefited 110,900 patients, with 2024 seeing a 79.3% increase in licensed medical device usage and a 36.8% increase in medical tourism visits [3] - The introduction of visa-free policies for 59 countries and transit visa exemptions for China has facilitated international medical tourism, with a notable increase in per capita spending exceeding 12,000 yuan [3] Cultural and Tourism Development - The article discusses the cultural exchanges and exhibitions at the Hainan South China Sea Museum, which enhance local cultural heritage and tourism [6][7] - The local government is focusing on rural revitalization through cultural industry empowerment, creating beautiful rural clusters around the forum venue [9]